Madrigal Pharmaceuticals Announces Preliminary Fourth-Quarter and Full-Year Financial ResultsMadrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a renowned biopharmaceutical company specializing in innovative therapeutics for metabolic dysfunction-associa
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Madrigal Pharmaceuticals’s 8K filing here. Madrigal Pharmaceuticals Company Profile (Get Free Report) Madrigal Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) […]
More Stories
Employer Health Insurance Costs Rise as Workers Shoulder More of the Bill, Report Says
By Bill Pan Health care costs continued to rise for employers and workers this year, with employees paying more for...
The Color Revolution Comes Home: Ex-USAID Operatives, DSA Networks, and a Playbook Aimed at the American Republic
By Stephen Zogopoulos, USNN World News In the interview titled “DataRepublican: The Democrat Plan For A Color Revolution: Everything You...
Trump Admin Can Detain Illegal Immigrants Without Bond Hearings: Appeals Court
By Zachary Stieber President Donald Trump’s administration can hold illegal immigrants in detention without bond hearings, a full federal appeals...
Florida Mayor Arrested After Authorities Say She Paid Herself and Family State COVID Funds
By Jill McLaughlin State authorities arrested the mayor of the central Florida city of Kissimmee on Oct. 21, charging her...
American Express Laying Off 5 Percent of Workforce
By Andrew Moran American Express said it is laying off about 5 percent of its workforce. The global payment services...
Typhoon Champi Leaves 1 Dead, 350 Injured in Taiwan; Alters US-Japan Military Exercise
By Arthur Zhang Typhoon Champi left one person dead and 350 injured in Taiwan, disrupting air and rail travel and...